Kamel Besseghir
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems 8
- Hepatology top 5%
- Virology top 5%
- HIV Research and Treatment 3
- Biomaterials top 10%
- biodegradable polymer synthesis and properties 3
- Gastroenterology top 10%
-
- Ion Transport and Channel Regulation 7
- Signaling Pathways in Disease 3
-
- Drug Transport and Resistance Mechanisms 6
-
- Ocular Surface and Contact Lens 5
-
- Corneal Surgery and Treatments 4
- Co-authors
- Robert GurnyFrédéric LallemandO. Felt-BaeyensFrancine Béhar‐CohenF Roch-RamelJean‐Maurice DumontMaría J. Blanco‐PrietoFrançoise Roch‐Ramel
- Journals
- New England Journal of Medicine (1 paper)Journal of Biological Chemistry (1 paper)Gastroenterology (1 paper)
- Partner nations
- SwitzerlandFranceUnited States
In The Last Decade
Kamel Besseghir
34 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 108
- Pharmaceutical Science 398
- Hepatology 174
- Virology 94
- Biomaterials 145
- Gastroenterology 43
Countries citing papers authored by Kamel Besseghir
This map shows the geographic impact of Kamel Besseghir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamel Besseghir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamel Besseghir more than expected).
Fields of papers citing papers by Kamel Besseghir
This network shows the impact of papers produced by Kamel Besseghir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamel Besseghir. The network helps show where Kamel Besseghir may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kamel Besseghir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Debio-025, a novel non-immunosuppressive cyclosporine analog with potent anti-human immunodeficiency virus type I activity: Pharmacological properties and mode of action | 2005 | 1 |
| 2 | 2005 | 64 | |
| 3 | 2005 | 34 | |
| 4 | 2004 | 20 | |
| 5 | 2004 | 113 | |
| 6 | Prevention of corneal graft rejection by eye drop instillation of UNIL088, a hydrosoluble prodrug of cyclosporin A | 2004 | 1 |
| 7 | 2003 | 194 | |
| 8 | 2001 | 144 | |
| 9 | 2000 | 15 | |
| 10 | 2000 | 46 | |
| 11 | 1999 | 75 | |
| 12 | 1998 | 29 | |
| 13 | 1992 | 28 | |
| 14 | 1990 | 6 | |
| 15 | 1990 | 26 | |
| 16 | 1989 | 5 | |
| 17 | 1987 | 37 | |
| 18 | 1986 | 3 | |
| 19 | 1985 | 5 | |
| 20 | 1981 | 12 |
About Kamel Besseghir
Kamel Besseghir is a scholar working on Pharmaceutical Science, Virology and Physiology, having authored 34 papers that have together received 1.3k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (8 papers), Ion Transport and Channel Regulation (7 papers), Drug Transport and Resistance Mechanisms (6 papers), Ocular Surface and Contact Lens (5 papers), Corneal Surgery and Treatments (4 papers), HIV Research and Treatment (3 papers), Signaling Pathways in Disease (3 papers) and biodegradable polymer synthesis and properties (3 papers). The work is most often cited by research in Pharmaceutical Science (398 citations), Hepatology (174 citations) and Virology (94 citations). Kamel Besseghir has collaborated with scholars based in Switzerland, France and United States. Frequent co-authors include Robert Gurny, Frédéric Lallemand, O. Felt-Baeyens, Francine Béhar‐Cohen, F Roch-Ramel, Jean‐Maurice Dumont, María J. Blanco‐Prieto, Françoise Roch‐Ramel, Bruno Gander and Urs T. Rüegg. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.